CLINICAL_TRIALS
trial_result
· 2024-09-24
Clinical Trial Update: A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) [Phase 3]
Summary
A Phase 3 study evaluating TAK-625 for Progressive Familial Intrahepatic Cholestasis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Progressive Familial Intrahepatic Cholestasis (PFIC) | Phase 3 | Status: COMPLETED | Results posted: 2024-09-24